Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase NA 1

Status

Completed 2Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Interventional 3Observational 2

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 20Precursor Cell Lymphoblastic Leukemia-Lymphoma 18Lymphoma, Follicular 17Lymphoma, B-Cell, Marginal Zone 17Leukemia, Myeloid, Acute 17Congenital Abnormalities 17Breast Neoplasms 16Lymphoma, Mantle-Cell 15Leukemia 15Lymphoma, Non-Hodgkin 14Lymphoma, Large B-Cell, Diffuse 14Multiple Myeloma 12Lymphoma, Large-Cell, Immunoblastic 11Lymphoma 11Burkitt Lymphoma 11Blast Crisis 11Myeloproliferative Disorders 10Myelodysplastic Syndromes 10Lymphoma, T-Cell, Cutaneous 10Leukemia, Myelomonocytic, Chronic 10Leukemia, Myeloid, Accelerated Phase 10Sezary Syndrome 9Mycosis Fungoides 9Leukemia, Myeloid, Chronic-Phase 9Waldenstrom Macroglobulinemia 8Lymphoma, Large-Cell, Anaplastic 8Hodgkin Disease 8Primary Myelofibrosis 7Pdgfra-Associated Chronic Eosinophilic Leukemia 6Neoplasms, Plasma Cell 6

Interventions

Gemcitabine 679130-nm albumin-bound paclitaxel 198Fluorouracil 186Oxaliplatin 175Albumin-Bound Paclitaxel 151Capecitabine 137Leucovorin 131Irinotecan 113Radiotherapy 95Taxes 83pembrolizumab 80Cisplatin 72Erlotinib Hydrochloride 69Radiosurgery 67Nivolumab 56Bevacizumab 54Drug Therapy 52Cyclophosphamide 49Magnetic Resonance Spectroscopy 46folfirinox 42Docetaxel 41Cetuximab 40Specimen Handling 37irinotecan sucrosofate 36S 1 (combination) 36Biopsy 31Radiation 29Paclitaxel 29Ipilimumab 27durvalumab 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Pancreatic Neoplasms × Flow Cytometry × Clear all
NCT01191684 2017-08-01

Vaccine Therapy in Treating Patients With Colorectal, Stomach, or Pancreatic Cancer

City of Hope Medical Center

Phase 1 Completed
12 enrolled
Gastrointestinal

Colonic Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms

NCT01413022 2016-09-19

FOLFIRINOX Plus PF-04136309 in Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma

Washington University School of Medicine

Phase 1 Completed
44 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT00524069 2013-02-01

Gemcitabine, Capecitabine, and Bevacizumab in Treating Patients With Pancreatic Cancer That Can Be Removed By Surgery

Roswell Park Cancer Institute

Phase NA Withdrawn
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡